Latest filings (excl ownership)
15-12G
Securities registration termination
26 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Feb 24
RW
Registration withdrawal request
16 Feb 24
SC 13E3/A
Going private transaction (amended)
16 Feb 24
25-NSE
Exchange delisting
16 Feb 24
8-K
Eargo Announces Closing of Acquisition By Patient Square Capital
16 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
14 Feb 24
DEFA14A
Additional proxy soliciting materials
7 Feb 24
SC 13E3/A
Going private transaction (amended)
16 Jan 24
DEFM14A
Proxy related to merger
16 Jan 24
SC 13E3/A
Going private transaction (amended)
5 Jan 24
PRER14A
Preliminary revised proxy
5 Jan 24
SC 13E3/A
Going private transaction (amended)
28 Dec 23
PRER14A
Preliminary revised proxy
28 Dec 23
8-K
Departure of Directors or Certain Officers
22 Dec 23
DEFA14A
Additional proxy soliciting materials
1 Dec 23
SC 13E3
Going private transaction
21 Nov 23
PREM14A
Preliminary proxy related to merger
21 Nov 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Entry into a Material Definitive Agreement
30 Oct 23
8-K
Eargo To Be Taken Private By Patient Square Capital
30 Oct 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Eargo Reports Second Quarter 2023 Financial Results
10 Aug 23
8-K
Cost Associated with Exit or Disposal Activities
27 Jun 23
8-K/A
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Departure of Directors or Certain Officers
9 Jun 23
SD
Conflict minerals disclosure
30 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Eargo Reports First Quarter 2023 Financial Results
11 May 23
ARS
2022 FY
Annual report to shareholders
24 Apr 23
DEFA14A
Additional proxy soliciting materials
24 Apr 23
DEF 14A
Definitive proxy
24 Apr 23
S-8
Registration of securities for employees
23 Mar 23
10-K
2022 FY
Annual report
23 Mar 23
8-K
Eargo Reports Fourth Quarter 2022 Financial Results
23 Mar 23
424B3
Prospectus supplement
13 Feb 23
424B3
Prospectus supplement
13 Feb 23
EFFECT
Notice of effectiveness
13 Feb 23
Latest ownership filings
4
William Brownie
20 Feb 24
4
Onkarr Narula
20 Feb 24
4
David James Wu
20 Feb 24
4
Afshin Justin Sabet-Peyman
20 Feb 24
4
KATIE J BAYNE
20 Feb 24
4
Donald J Spence
20 Feb 24
4
Mark Thorpe
20 Feb 24
4
Trit Garg
20 Feb 24
SC 13D/A
PSC Echo, LP
16 Feb 24
4
Mark Thorpe
30 Nov 23
4
Adam Laponis
22 Nov 23
144
Notice of proposed sale of securities
20 Nov 23
144
Notice of proposed sale of securities
17 Nov 23
144
Notice of proposed sale of securities
17 Nov 23
4
Mark Thorpe
17 Nov 23
4
William Brownie
17 Nov 23
4
Adam Laponis
17 Nov 23
144
Notice of proposed sale of securities
15 Nov 23
4
William Brownie
15 Nov 23
144
Notice of proposed sale of securities
13 Nov 23
SC 13D/A
PSC Echo, LP
30 Oct 23
144
Notice of proposed sale of securities
17 Aug 23
4
William Brownie
17 Aug 23
4
Adam Laponis
17 Aug 23
4
Mark Thorpe
17 Aug 23
144
Notice of proposed sale of securities
17 Aug 23
144
Notice of proposed sale of securities
17 Aug 23
4
Donald J Spence
9 Jun 23
4
David James Wu
9 Jun 23
4
Trit Garg
9 Jun 23
4
Afshin Justin Sabet-Peyman
9 Jun 23
4
KATIE J BAYNE
9 Jun 23
4
Onkarr Narula
9 Jun 23
4
Christian Gormsen
18 May 23
4
William Brownie
18 May 23
4
Adam Laponis
18 May 23
4
Mark Thorpe
18 May 23
144
Notice of proposed sale of securities
17 May 23
144
Notice of proposed sale of securities
17 May 23
144
Notice of proposed sale of securities
17 May 23